Team:Imperial College London/Parts

From 2010.igem.org

(Difference between revisions)
 
(10 intermediate revisions not shown)
Line 1: Line 1:
-
 
-
 
{{:Team:Imperial_College_London/Templates/Header}}
{{:Team:Imperial_College_London/Templates/Header}}
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
{{:Team:Imperial_College_London/Templates/PartsHeader}}
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:5px;" cellspacing="20"
-
|-
+
|<html><iframe src="http://partsregistry.org/cgi/partsdb/pgroup.cgi?pgroup=iGEM2010&group=Imperial_College_London" width="100%" height="600px"></iframe></html>
-
|'''We have contributed 23 parts to the Registry of Standard Biological Parts. We hope that other people will find the useful in the future. For more information on the individual parts, see below.'''
+
-
|}
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316012 - 3' K316000-sRBS-TEV**==
+
-
 
+
-
Name: 3' coding, Enhanced LacI inducible promoter, synthetic RBS, TEV
+
-
 
+
-
Code: BBa_K316000
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: 3' coding TEV protease under control of enhanced Lac operon
+
-
 
+
-
Long:
+
-
 
+
-
TEV protease S219P autocatalysis resistant variant
+
-
 
+
-
Introduction :
+
-
 
+
-
This is the nuclear inclusion protease, endogenous to Tobacco Etch Virus and is used in the late lifecycle to cleave polyprotein precursors. The recognition sequence is ENLYFQG/S [http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6W9V-45PMGK3-9P&_user=217827&_coverDate=02%2F01%2F1994&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000011279&_version=1&_urlVersion=0&_userid=217827&md5=e075aad3a349720ad9484095d01a65be&searchtype=a]] between QG or QSDue to it’s stringent sequence specificity, TEV is commonly used to cleave genetically engineered proteins.
+
-
 
+
-
Uses:
+
-
 
+
-
TEV proteinase is used to cleave fusion proteins. It is useful due to its high degree of specificity [[http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6W9V-45PMGK3-9P&_user=217827&_coverDate=02%2F01%2F1994&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000011279&_version=1&_urlVersion=0&_userid=217827&md5=e075aad3a349720ad9484095d01a65be&searchtype=a]] and potential to be used in vivo or in vitro applications.
+
-
 
+
-
 
+
-
Auto-inactivation
+
-
 
+
-
Wild type TEV protease also cleaves itself at Met 218 and Ser 219 [[http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WXR-45R86R6-5X&_user=7635175&_coverDate=06%2F20%2F1995&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000011279&_version=1&_urlVersion=0&_userid=7635175&md5=0a1521e783c0bd4126b145f3f6d766d4&searchtype=a]]
+
-
. This leads to auto-inactivation of the TEV protease and progressive loss of activity of the protein. The rate of inactivation is proportional to the concentration of protease [[http://peds.oxfordjournals.org/content/14/12/993.long ]]
+
-
 
+
-
More stable Mutants have been produced by single amino acid substitutions S219V (AGC(serine) to GTG(valine) and S219P (AGC(serine) to CCG(proline)
+
-
 
+
-
Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency
+
-
+
-
'''Table I.''' Kinetic parameters for wild-type and mutant TEV proteases with the peptide substrate TENLYFQSGTRR-NH2.
+
-
Enzyme Km (mM) kcat (s−1) kcat/Km (mM−1 s−1)
+
-
Wild-type 0.061 ± 0.010 0.16 ± 0.01 2.62 ± 0.46
+
-
S219V* 0.041 ± 0.010 0.19 ± 0.01 4.63 ± 1.16
+
-
S219P* 0.066 ± 0.008 0.09 ± 0.01 1.36 ± 0.22
+
-
 
+
-
S219P* - virtually imperivious to autocatalysis
+
-
S219V* - retains same activity as wild type
+
-
 
+
-
Full article can be seen here [[http://peds.oxfordjournals.org/content/14/12/993.long]]
+
-
 
+
-
 
+
-
 
+
-
 
+
-
Source: TEV protease is naturally found in Tobacco Etch Virus genome. This part contains the sequence codon optimized for expression in B.subtilis using mwg – eurofins [[www.eurofinsdna.com]]  proprietary software.
+
-
 
+
-
Design: The part was produced by nucleotide synthesis by mwg – eurofins
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316001 - Pveg**==
+
-
 
+
-
Name: Pveg promoter
+
-
 
+
-
Code: BBa_K316001
+
-
 
+
-
Sequence: ACGT etc.
+
-
 
+
-
Short: pVeg Constitutive promoter for Veg locus from B. subtilis
+
-
 
+
-
Long: This part is identical to the sequence submitted by Imperial 2008 team, this part was produced from BBa_K143053 by PCR. PVeg is a constitutive promoter controlled by Sigma factor A. This promoter has two binding sites which leads to high expression of downstream genes. There is some evidence that the sporulation master regulator the spoOA can interact with pVeg although the mechanism is not known.
+
-
 
+
-
Source: PCR from existing biobrick K143053 using Pfu polymerase II
+
-
 
+
-
Design: PCR using Pfu polymerase to avoid mutations
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316002 - dif**==
+
-
 
+
-
Name: B. subtilis dif excision site
+
-
 
+
-
Code: BBa_K316002
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: B. subtilis dif: sequence-specific recombinase target site
+
-
 
+
-
Long:
+
-
 
+
-
===<big>''B. subtilis'' ''dif'': sequence-specific recombinase recognition site</big>===
+
-
 
+
-
Cells with circular chromosomes, recombinatorial repair and homologous recombination can generate multimeric chromosomes <cite>1</cite>. ‘’Dif’’ sites are part of a system to ensure that multimeric chromosomes can be separated to monomers, which is required for proper sharing of genetic material between daughter cells.
+
-
In ‘’B. subtilis’’ the tyrosine family recombinases such as RipX and CodV mediate the separation at 28-bp sequence Bs’’dif’’ <cite>1</cite>. The site-specific recombinases are able to recognize two directly repeated ’’dif’’ sites and excise the fragment flanked by the two sites <cite>2</cite>.
+
-
 
+
-
 
+
-
 
+
-
[[Image:DifExcision.PNG|center|800px]]
+
-
 
+
-
''http://partsregistry.org/Image:DifExcision.PNG''
+
-
 
+
-
===<big>Figure 1. Removal of a specific gene from a genome integrated construct.</big>===
+
-
 
+
-
 
+
-
The site-specific recombinases, endogenous to ‘’B. subtilis’’ strains are able to recognise Bs’’dif’’ sites and recombine out the strand of DNA directly flanked by the two sites. Recombination leaves a single dif site.
+
-
 
+
-
The construct was previously engineered to homologously recobine into the genome of ‘’B. subtilis’’. Integration sequences such as amyE <bbpart>BBa_J143001</bbpart>, <bbpart>BBa_J143002</bbpart> can be used to achieve this.
+
-
 
+
-
Source: The dif sites were made by annealing synthestised oligoes.
+
-
 
+
-
Design: The dif site was made by oligos designed to make overhangs for EcoRI and SpeI ( and ) or XbaI and PstI ( and ) to be used in standard Biobrick or 3A cloning.
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
===References===
+
-
<biblio>
+
-
#1 pmid=11208805
+
-
#2 pmid=16597952
+
-
 
+
-
 
+
-
https://2010.igem.org/Team:Imperial_College_London
+
-
 
+
-
</biblio>References
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316003 - XylE-B0014** ==
+
-
 
+
-
Name: XylE, Double Terminator
+
-
 
+
-
Code: BBa_S04510
+
-
 
+
-
Sequence:
+
-
 
+
-
Short:
+
-
XylE - catechol 2,3-dioxygenase from P.putida with terminator
+
-
 
+
-
Long:
+
-
Catechol or catechol 2,3-dioxygenase + O(2) is converted by a ring cleavage into 2-hydroxymuconate semialdehyde which is the toxic and bright yellow-coloured substrate.  This is a key enzyme in many (soil) bacterial species used for the degradation of aromatic compounds. The catechol 2,3-dioxygenase (pdb id: 1MPY[http://www.ebi.ac.uk/pdbsum/1mpy])  used here itself originating from Pseudomonas putida is a homotetramer of C230 monomers. The tetramerization interactions position a ferrous ion critical for enzymatic activity. It has been deduced that intersubunit interaction is essential to produce a functioning enzyme after performing N and C terminal modifications on the monomer. Coming together the subunits generate an active site.
+
-
The reaction itself takes place within seconds after the addition by Pasteur pipette or spraying of catechol at a 100mM stock solution diluted with DDH20 (used by our lab.)
+
-
The toxic byproduct is thought to interfere with cell wall integrity and cellular machinery such that exposed cells gradually die.
+
-
 
+
-
Catechol 2,3-dioxygenase
+
-
 
+
-
Source:
+
-
XylE was obtained from the registry <bbpart>BBa_K118021</bbpart>, the terminator is <bbpart>BBa_B0014</bbpart>. XylE is naturally found in Pseudomonas putida.
+
-
 
+
-
Design:
+
-
The parts were put together using standard assembly [http://partsregistry.org/Assembly:Standard_assembly]
+
-
 
+
-
 
+
-
== References:
+
-
PubMed id: 10368270]
+
-
http://www.ebi.ac.uk/pdbsum/1mpy
+
-
Biochem. J. (2003) 371, 557–564 (Printed in Great Britain) 557
+
-
Intersubunit interaction and catalytic activity of catechol 2,3-dioxygenases
+
-
Akiko OKUTA1, Kouhei OHNISHI2,3, Sakiko YAGAME and Shigeaki HARAYAMA
+
-
Marine Biotechnology Institute, 3-75-1 Heita, Kamaishi, Iwate 026-0001, Japan
+
-
 
+
-
 
+
-
</biblio> ==
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316004 - J23101-XylE-B0014** ==
+
-
 
+
-
Name: Constitutive E-coli promoter, XylE, double  terminator
+
-
 
+
-
Code: BBa_K316004
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: Functional XylE under J23101 promoter, with B0014 terminator
+
-
 
+
-
Long: <bbpart>BBa_J23101</bbpart> combined with <bbpart>BBa_S04510</bbpart>for easy characterisation of gene activity (catechol breakdown into 2,4 hydroxyaminobutane yellow product) under a standard E.coli promoter
+
-
 
+
-
Source: Biobrick parts <bbpart>BBa_J23101</bbpart> and <bbpart>BBa_S04510</bbpart>
+
-
 
+
-
Design: Parts were assembled in two steps using standard biobrick assembly.
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316005 - K316001-XylE-B0014**==
+
-
 
+
-
Name: Pveg-XylE-Double Terminator
+
-
 
+
-
Code: BBa_K316005
+
-
 
+
-
Sequence:
+
-
 
+
-
Short:  Functional XylE under Pveg promoter, with B0014 terminator
+
-
 
+
-
Long: Enables characterization and comparison with alternative promoters e.g. <bbpart>BBa_J23101</bbpart> Designed for characterisation of XylE in Bacillus subtilis where Pveg is becoming a standard promoter
+
-
 
+
-
Source: Biobrick parts <bbpart>BBa_J33204</bbpart> <bbpart>BBa_B0014</bbpart>
+
-
 
+
-
Design: Parts were assembled in two steps using standard biobrick assembly.
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316006 - 5'hisGFP-XylE**==
+
-
 
+
-
Name: 5'his tagged-GFP-XylE fusion protein
+
-
 
+
-
Code: BBa_K316006
+
-
 
+
-
Sequence:
+
-
 
+
-
Short:
+
-
5'His-tagged GFP linked to XylE by TEV cleavable linker
+
-
 
+
-
Long:
+
-
Constructed to be combined with promoter and terminator. The GFP <bbpart>BBa_E0040</bbpart> is linked to XylE <bbpart>BBa_J33204</bbpart> monomer subunit by a GGGSGGGS linker with the aim to render the enzyme inactive, via preventing tetramerization (it’s functional form).
+
-
 
+
-
Please see ‘Part Design’ section for design considerations and parts used.
+
-
 
+
-
Source: Existing biobrick parts with modifications using PCR primer extension
+
-
 
+
-
Design: ''''PCR primer extension - exact methods our wiki [https://2010.igem.org/Team:Imperial_College_London/Strategy]'''''
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316007 - K143053-GFP-XylE**==
+
-
 
+
-
Name: '''B. subtilis promoter Pveg and strong RBS spoVG <bbpart>BBa_K143053</bbpart>''', 5'His tagged GFP-linker-XylE fusion protein
+
-
 
+
-
Code: BBa_K316007
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: Cleavable GFP-XylE protein under Pveg promoter
+
-
 
+
-
Long: This construct is designed so that the XylE activity is substantially reduced untill such a time when a TEV protease is added to the system and transcribed. TEV protease cleavable linker is positioned between the two proteins. Once the linker is cleaved, XylE is free to tetramerise and assume full activity. GFP is His tagged at the 5' end to facilitate purificaiton for in-vitro assays.
+
-
 
+
-
Source: Pveg and spoVG biobricks <bbpart>BBa_K143053</bbpart> added to GFP-XylE construct <bbpart>BBa_K316004</bbpart>.
+
-
 
+
-
Design: Standard biobrick cloning of '''intermediary parts add part numbers <bbpart>BBa_K143053</bbpart>'''
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316008 - K143053-5'hisGFP-linker-XylE-B0014**==
+
-
 
+
-
Name: B. subtilis promoter Pveg and strong RBS spoVG <bbpart>BBa_K143053</bbpart>, 5'His tagged GFP-linker-XylE fusion protein <bbpart>BBa_K316005</bbpart>, double terminator <bbpart>BBa_B0014</bbpart>
+
-
 
+
-
Code: BBa_K316008
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: Cleavable GFP-XylE fusion with Pveg promoter and terminator
+
-
 
+
-
Long: This construct is designed so that the XylE activity is substantially reduced untill such a time when a TEV protease is added to the system and transcribed. TEV protease cleavable linker is positioned between the two proteins. Once the linker is cleaved, XylE is free to tetramerise and assume full activity. GFP is His tagged at the 5' end to facilitate purificaiton for in-vitro assays. Terminator <bbpart>BBa_B0014</bbpart> has been added to comply with Biobrick standards. This particular terminator is stronger and is different from <bbpart>BBa_B0015</bbpart>.
+
-
 
+
-
Source: Existing Biobricks  <bbpart>BBa_K143053</bbpart>, <bbpart>BBa_K316005</bbpart>, <bbpart>BBa_B0015</bbpart>
+
-
 
+
-
Design: Standard Biobrick assembly
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316009 -TEV-sRBS-K316000 -'''K143053'''-5'hisGFP-linker-XylE-B0014**==
+
-
 
+
-
Name: minus strand encoded - LacI inducible TEV and plus strand 5'his tagged-GFP-linker-XylE construct under constitutive Pveg promoter and spoVG RBS <bbpart>BBa_K143053</bbpart>
+
-
 
+
-
Code: BBa_K316009
+
-
 
+
-
Sequence:
+
-
 
+
-
Short:
+
-
LacI inducible Fast Response Module, using cleavable XylE
+
-
 
+
-
Long:
+
-
 
+
-
5' his tagged GFP-TEV linker-XylE construct is pre-made in the cell under constitutive promoter. Both Pveg promoter and spoVG RBS are best suited for maximal expression in B.subtilis. While GFP is attached to the XylE monomer via the TEV cleavable linker, the catalytic activity is low. Transcription of TEV protease allows cleavage of the linker between GFP and XylE, thus XylE is free to tetramerise into a fully functional enzyme. XylE is then able to act as described in <bbpart>BBa_k316004</bbpart>
+
-
 
+
-
Please see 'Part Design' section for design considerations and parts used.
+
-
 
+
-
Source: Made from parts - <bbpart>BBa_k316012</bbpart> and <bbpart>BBa_k316008</bbpart>
+
-
 
+
-
Design: Standard biobrick assembly
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==K316010 -** 3' encoded K316000 - XylE**==
+
-
 
+
-
Name: LacI inducible XylE
+
-
 
+
-
Code: BBa_K316010
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: 3' strand coding XylE under LacI activation
+
-
 
+
-
Long: This part contains XylE under synthetic hyperspank promoter <bbpart>BBa_K143000</bbpart> LacI and IPTG are required for repression and activation of expression. As transformation of B subtilis often requires genomic integration, read-through from upstream genomic regions can become an issue. For the purposes of characterisation, the part was made on the minus strand to reduce background transcription. Read-through may provide an additional benefit as low quantities of anti-sence RNA may reduce basal expression sometimes seen in LacI systems. (although there is some evidence background is usually due to readthrough if have ref)
+
-
 
+
-
Source:
+
-
 
+
-
Design: the part contains a synthetic RBS optimised for high expression in B subtilis, calculated using RBS calculator [ link ]
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
+
-
|}
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==K316011 - Flipped Xyle==
+
-
 
+
-
Name: Flipped XylE
+
-
 
+
-
Code: BBa_K316011
+
-
 
+
-
Sequence:
+
-
 
+
-
 
+
-
Short: Reverse strand coding XylE
+
-
 
+
-
Long: This part contains XylE coding on the 3' strand. In many biological settings there may be read-through caused by upstream elements, however this can often be unidirectional. In settings where readthrough from 5' direction is expected to be much stronger than 3' direction, it may is advantageous to use 3' coding sequence instead of traditional 5'.
+
-
 
+
-
For the purposes of characterisation, the part was made on the minus strand to reduce background transcription. Read-through from 5' direction may provide an additional benefit. Low quantities of anti-sence RNA may be produced as the result of 5' readthrough, which may in turn reduce basal expression sometimes seen in LacI systems.
+
-
 
+
-
Source: This part is a modified existing biobrick <bbpart>BBa_J33204</bbpart>
+
-
 
+
-
Design: Part was designed using several rounds of PCR, using Pfu polymerase to avoid mutations. For more information, please check our wiki[https://2010.igem.org/Team:Imperial_College_London/Strategy]
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316000 - Pehs** ==
+
-
 
+
-
Name: Enhanced hyperspank promoter
+
-
 
+
-
Code: BBa_K316000
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: 3' coding Enhanced LacI-hyperspank promoter
+
-
 
+
-
Long:
+
-
 
+
-
This part is a modified version of hyper-spank promoter for B.subtilis <bbpart>BBa_K143015</bbpart>.  Hyper-spank promoter is repressed by transcriptional repressor LacI <bbpart>BBa_K143033</bbpart> and can be induced by addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG). Constitutive expression of LacI is required for repression.
+
-
 
+
-
Promoter Design
+
-
 
+
-
The position and sequence of LacI binding was designed using existing knowledge. The stochastic nature of transcriptional repressors usually leads to background transcription. In order to minimise background the binding sites and the distance between them have been optimised.
+
-
 
+
-
Stronger binding
+
-
 
+
-
The natural LacI operator has 3 binding sites, all of which have variations in the binding sequences. Perfectly symmetric binding sequence was shown to have10-fold higher binding compared to wild type sequences. The aattgtgagc gctcacaatt sequence has been shown to be optimal for LacI binding Muller 1996 Oehler 1994.
+
-
 
+
-
Optimal distance
+
-
 
+
-
Due to the tetrameric nature of LacI it can simulataneously bind to multiple regions in the genome. Binding at multple sites can produce much stronger repression (muller 1996) by increasing local LacI concentrations. Due to the helical nature of DNA the distance between the operator sites plays an important role in the strength of repression. Maximal repression at 70.5bp, second strongest at 92.5bp and third at 115.5bp
+
-
 
+
-
 
+
-
Source:
+
-
 
+
-
Design: Designed for minimal basal transcription by altering binding site sequence and distance.
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316013 - PmeI cutting site** ==
+
-
 
+
-
Name: PmeI recognition sequence
+
-
 
+
-
Code: BBa_K316014
+
-
 
+
-
Sequence:
+
-
 
+
-
Short:  8bp recognition sequence for PmeI restriction endonuclease
+
-
 
+
-
Long:
+
-
 
+
-
Information about PmeI restriction endonuclease is available at [http://www.neb.com/nebecomm/products/productR0560.asp]. The recognition site is a 8bp sequence GTTTAAAC. Pme produces a blunt cut after GTTT.
+
-
 
+
-
Source: This is a planning part. The sequence was combined with <bbpart>BBa_K143000</bbpart> to produce <bbpart>BBa_K143014</bbpart> in construction of B. subtilis genome integration vectors
+
-
 
+
-
Design: This is a planning part. The sequence was produced from single stranded primer oligos.
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316014 - K316000-K316013** ==
+
-
 
+
-
Name: Dif Pme
+
-
 
+
-
Code: BBa_K316014
+
-
 
+
-
Sequence:
+
-
 
+
-
Short:  Dif sequence followed by PmeI recognition site
+
-
 
+
-
Long:
+
-
 
+
-
This composite part of <bbpart>BBa_K143000</bbpart> and <bbpart>BBa_K143013</bbpart>. The dif site can be used in conjunction with another dif site in another part of the vector to remove a sequence between the two dif sites. PmeI site can be used for blunt end cloning of a DNA sequence behind the dif site.
+
-
 
+
-
Source: oligonucleotide synthesis
+
-
 
+
-
Design: This part was designed to be cloned using standard biobrick methods. Two single stranded, synthetic oligos were annealed to produce double stranded DNA sequence with single stranded overhangs identical to the product of digestion by XbaI and SpeI. Thus compatible with biobrick cloning methods.
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316015 - ComD**==
+
-
 
+
-
Name: ComD Receptor
+
-
 
+
-
Code: BBa_K316015
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: ComD receptor for CSP-1 (S. pneumoniae). Phosphorylates ComE
+
-
 
+
-
Long: ComD is the histidine kinase of a two-component signal transduction signaling pathway in a Streptococcus pneumoniae quorum sensing system. It detects the linear autoinducing peptide (AIP) called Competence-Stimulating Peptide-1 (CSP-1) which is coded for by the ComC gene.
+
-
Upon detection of CSP-1, ComD will autophosphoylate and then phosphorylate and activate the response regulator, ComE
+
-
 
+
-
Source: Streptococcus pneumoniae,  AAC44896.1, codon optimised for expression in B.subtilis
+
-
 
+
-
Design: the part contains a synthetic RBS optimised for high expression in B subtilis, calculated using RBS calculator [ link ]
+
-
 
+
-
References:
+
-
 
+
-
Info on threshold levels of CSP-1 etc [[http://ukpmc.ac.uk/backend/ptpmcrender.cgi?accid=PMC40587&blobtype=pdf]]
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316016 -ComE**==
+
-
 
+
-
Name: LacI inducible XylE
+
-
 
+
-
Code: BBa_K316016
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: Activates transcription of target genes when phosphorylated.
+
-
 
+
-
Long: ComE is the response regulator of a two-component signal transduction signaling pathway in a Streptococcus pneumoniae quorum sensing system. It is phosphorylate and activated by ligand-bound ComD. It will then induce transcription of any gene which has a ComE binding site in its promoter.
+
-
 
+
-
 
+
-
Source: Streptococcus pneumoniae, AAC44897, codon optimised for expression in B. subtilis
+
-
 
+
-
Design: Synthetic RBS to optimise translation in B. subtilis as part of poly-mRNA containing ComD upstream
+
-
 
+
-
References:
+
-
 
+
-
Designing a ComE binding site: [[http://onlinelibrary.wiley.com/doi/10.1111/j.1574-6968.2006.00584.x/full]]
+
-
Dimerisation of ComE and more info on binding site: [[http://jb.asm.org/cgi/content/full/186/10/3078]]
+
-
 
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316017 -TEV+B316000**==
+
-
 
+
-
Name: LacI inducible TEV protease
+
-
 
+
-
 
+
-
Short
+
-
 
+
-
LacI operator controlled TEV protease
+
-
 
+
-
Long
+
-
 
+
-
 
+
-
TEV protease S219P autocatalysis resistant variant <bbpart>BBa_K316012</bbpart>. This part had been reversed for the 3' strand in order to reduce any read-through that may be caused by upstream elements. Expression of TEV protease is under control of enhanced hyperspank promoter <bbpart>BBa_K316000</bbpart>.
+
-
 
+
-
''Please note all the sequences of this part are reversed to code on 3' strand''
+
-
 
+
-
 
+
-
 
+
-
The part was produced by nucleotide synthesis by mwg – eurofins. The synthetic RBS was designed to work with <bbpart>BBa_K316000</bbpart>.
+
-
 
+
-
 
+
-
TEV protease is naturally found in Tobacco Etch Virus genome. This part contains the sequence codon optimized for expression in B.subtilis using mwg – eurofins [www.eurofinsdna.com] proprietary software.
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316018 -Com CDE forward==
+
-
 
+
-
Name: ComE responsive promoter
+
-
 
+
-
 
+
-
Short
+
-
 
+
-
ComE responsive promoter
+
-
 
+
-
Long
+
-
 
+
-
ComE binds to a specific sequence leading to activation of trancription.
+
-
 
+
-
 
+
-
 
+
-
The part was produced by nucleotide synthesis by mwg – eurofins. The synthetic RBS was designed to work with <bbpart>BBa_K316000</bbpart>.
+
-
 
+
-
 
+
-
TEV protease is naturally found in Tobacco Etch Virus genome. This part contains the sequence codon optimized for expression in B.subtilis using mwg – eurofins [www.eurofinsdna.com] proprietary software.
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316020 -pyrD complete vector-K143008-K316002-K143053-K143065-K316014-K143009**==
+
-
 
+
-
Name: B. subtilis genome integration vector into pyrD locus
+
-
 
+
-
Code: BBa_K316020
+
-
 
+
-
Sequence:
+
-
 
+
-
Short: B. subtilis genome integration vector into pyrD locus
+
-
 
+
-
Long:
+
-
 
+
-
'''PyrD'''
+
-
This vector has been designed using the Pyrd 5' <bbpart>BBa_K143001</bbpart> and 3' <bbpart>BBa_K143002</bbpart> integration sequences for integration into ''B. subtilis'' genome. Insertion into the pyrD locus provides a negative selection marker as the bacterium will no longer be able to synthesise uracil. Thus medium supplement of 40ug/ml is required for growth. This phenotype makes the transformed bacterium considerably less likely to survive in natural environments.
+
-
 
+
-
'''Spectinomycin Resistance'''
+
-
This vector also contains a positive selection marker, flanked by two dif sites. Aad9 <bbpart>BBa_K143065</bbpart> provides resistance to spectinomycin antibiotic. Dif <bbpart>BBa_K316002</bbpart> sites allow excision of the antibiotic marker after integration, thus allowing the same marker to be used again or as a precaution against horizontal gene transfer.
+
-
 
+
-
'''Blunt end cloning site'''
+
-
PmeI restriction site <bbpart>BBa_K316013</bbpart> is designed as a cloning site. Due to the 8bp recognition sequence it is a rare site that can be used to cut the vector only once.
+
-
 
+
-
 
+
-
Please see ‘Part Design’ section for design considerations and parts used.
+
-
 
+
-
Source: Existing biobricks, <bbpart>BBa_K143008</bbpart>, <bbpart>BBa_K316002</bbpart>, <bbpart>BBa_K143053</bbpart> <bbpart>BBa_K143065</bbpart> <bbpart>BBa_K316014</bbpart> <bbpart>BBa_K143009</bbpart>
+
-
 
+
-
Design: Using standard assembly of biobricks
+
-
 
+
-
BBa_K143008 BBa_K316002 BBa_K143053 BBa_K143065 BBa_K316014 BBa_K143009
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
==**BBa_K316021 BBa_K143053 BBa_K143065**==
+
-
 
+
-
Name: Pveg-spoVG-Spec-B0015
+
-
 
+
-
Code: BBa_K316021
+
-
 
+
-
Sequence:
+
-
 
+
-
Short:
+
-
 
+
-
Spectinomycin resistance with promoter for B.subtilis
+
-
 
+
-
Long:
+
-
 
+
-
For reliable expression in B. subtilis the strongest constitutive promoter Pveg and strong ribosome binding site spoVG <bbpart>BBa_K143053</bbpart> were combined with spectinomycin resistance gene with terminator <bbpart>BBa_J143065</bbpart>.
+
-
 
+
-
Please see ‘Part Design’ section for design considerations and parts used.
+
-
 
+
-
 
+
-
 
+
-
Source:
+
-
 
+
-
Existing biobricks <bbpart>BBa_K143053</bbpart>, <bbpart>BBa_J143065</bbpart>
+
-
 
+
-
Design considerations:
+
-
 
+
-
Standard biobrick assembly [http://partsregistry.org/Assembly:Standard_assembly]
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
 
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|==**K316022 - K143001-k316002-K143053-K143065-K316002-K316014-K143002** ==
+
-
 
+
-
Name:amyE complete vector 5'amyE-diff-Pveg-spoVG-CAT-B0015-diff-PmeI-3'amyE
+
-
 
+
-
Code: BBa_K316022
+
-
 
+
-
Sequence:
+
-
 
+
-
Short:
+
-
 
+
-
B.subtilis transformation vector, targets Amylase locus
+
-
 
+
-
Long:
+
-
 
+
-
This vector has been designed using the amyE 5' and 3' integration sequences for integration into B.subtilis genome
+
-
 
+
-
'''AmyE locus'''
+
-
This vector has been designed using the amyE 5' <bbpart>BBa_K143008</bbpart> and 3 <bbpart>BBa_K143009</bbpart>' integration sequences for integration into ''B. subtilis'' genome. Insertion into the amyE locus provides a selection marker as the bacterium will no longer be able to breakdown starch. An iodine assay can be used to confirm integration. This phenotype makes the transformed bacterium considerably less likely to survive in natural environments.
+
-
 
+
-
'''Chloramphenicol Resistance'''
+
-
This vector also contains a positive selection marker, flanked by two dif sites. Chloramphenicol acetyltransferase <bbpart>BBa_J31005</bbpart> provides resistance to chloramphenicol antibiotic. Dif <bbpart>BBa_K316002</bbpart> sites allow excision of the antibiotic marker after integration, thus allowing the same marker to be used again or as a precaution against horizontal gene transfer.
+
-
 
+
-
'''Blunt end cloning site'''
+
-
PmeI restriction site <bbpart>BBa_K316013</bbpart> is designed as a cloning site. Due to the 8bp recognition sequence it is a rare site that can be used to cut the vector only once.
+
-
 
+
-
 
+
-
Please see ‘Part Design’ section for design considerations and parts used.
+
-
 
+
-
 
+
-
 
+
-
 
+
-
 
+
-
Source: Existing biobricks, <bbpart>BBa_K143070</bbpart>, <bbpart>BBa_K316002</bbpart>,  <bbpart>BBa_K316014</bbpart> <bbpart>BBa_K143002</bbpart>
+
-
 
+
-
Design: the part contains a synthetic RBS optimised for high expression in B subtilis, calculated using RBS calculator [ link ]
+
-
 
+
-
BBa_K143001 BBa_K316002 BBa_K143052 BBa_J31005 BBa_K316014 BBa_K143002
+
-
 
+
-
BBa_K143001 BBa_K143052 BBa_J31005 BBa_K143002
+
-
 
+
-
References: Very helpful if you have them!
+
-
 
+
-
<biblio>
+
-
 
+
-
</biblio>
+
-
 
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
-
|}
+
-
 
+
-
{| style="width:900px;background:#f5f5f5;text-align:justify;font-family: helvetica, arial, sans-serif;color:#555555;margin-top:25px;" cellspacing="20"
+
-
|style="font-family: helvetica, arial, sans-serif;font-size:2em;color:#ea8828;"|Parts
+
-
|-
+
-
|
+
|}
|}

Latest revision as of 18:35, 27 October 2010

Parts Favourites | Full List
We have contributed 23 parts to the Registry of Standard Biological Parts and we really hope that other people will find them useful in the future. Here you can find detailed information on our favourite parts, or the registry information on the complete parts list.
Retrieved from "http://2010.igem.org/Team:Imperial_College_London/Parts"